Baihua Pharmaceutical: Xinjiang Baihuacun Pharmaceutical Group Co., Ltd. 2021 Stock Option Incentive Plan Results and Stock Change Announcement for the Third Quarter of 2024
Xinjiang Baihuacun Pharmaceutical Group Co., Ltd. 2021 Stock Options Incentive Plan 2024 Third Quarter Enforcement Results and Stock Change Notice
An indicative announcement by Xinjiang Baihuacun Pharmaceutical Group Co., Ltd. on the restricted exercise period of the 2021 Stock Options Incentive Plan
An indicative announcement by Xinjiang Baihuacun Pharmaceutical Group Co., Ltd. on granting a third exercise period for the first time in the 2021 stock options incentive plan and reserving the granting of the second exercise period to commence the exercise of rights
Announcement of Progress on Pledged Shares of Controlling Shareholder by Xinjiang Baihuacun Pharmaceutical Group Co., Ltd.
Announcement on the release and re-pledging of shares by the controlling shareholder of Xinjiang Baihua Village Pharmaceutical Group Co., Ltd.
Announcement of Xinjiang Baihua Village Pharmaceutical Group Co., Ltd. on the completion of the cancellation of the stock options in the 2021 stock option incentive plan.
Announcement on the First Grant of Stock Options for the Third Exercise Period and Reserved Grant for the Second Exercise Period of the 2021 Stock Option Incentive Plan for Xinjiang Baihua Village Pharmaceutical Group Co., Ltd with the adoption of autonomous exercise model.
Announcement on the cancellation of a portion of the stock options for the 2021 stock option incentive plan by Xinjiang Baihuacun Pharmaceutical Group Co., Ltd.
Legal Opinion of Beijing Times Nine and Law Firm Regarding the 2021 Stock Option Incentive Plan of Xinjiang Baihua Village Pharmaceutical Group Co., Ltd., including the First Grant of the Third Exercise Period, Achievement of Conditions for Reserving the Second Exercise Period, and Cancellation of Some Stock Options.
Announcement of Xinjiang Baihuacun Pharmaceutical Group Co., Ltd. regarding the first grant of stock options for 2021 and the achievement of the exercise conditions reserved for the second exercise period
Announcement from Xinjiang Baihuacun Pharmaceutical Group Co., Ltd. regarding the receipt of the decision from Shanghai Stock Exchange to terminate the review of the issuance of stocks to specific targets.
Notice regarding the restricted exercise period of the 2021 stock option incentive plan of Xinjiang Baihuacun Pharmaceutical Group Co., Ltd.
Xinjiang Baihuacun Pharmaceutical Group Co., Ltd.'s 2021 stock option incentive plan second quarter exercise results in 2024 and shareholding changes announcement.
Announcement of Xinjiang Baihua Village Pharmaceutical Group Co., Ltd. regarding the termination of issuing stocks to specific individuals.
Announcement of Progress on Pledged Shares of Controlling Shareholder by Xinjiang Baihuacun Pharmaceutical Group Co., Ltd.
Announcement on Pledge of Shares by Controlling Shareholder of Xinjiang Baihua Village Medicine Group Co., Ltd.
Xinjiang Baihuacun Pharmaceutical Group Co., Ltd. 2021 Stock Options Incentive Plan 2024 First Quarter Enforcement Results and Stock Change Notice
An indicative announcement by Xinjiang Baihuacun Pharmaceutical Group Co., Ltd. on the restricted exercise period of the 2021 Stock Options Incentive Plan
Xinjiang Baihuacun Pharmaceutical Group Co., Ltd. 2021 Solution Verification Analysis Report on the Issuance of A Shares to Specific Targets (Revised Draft)
No Data
No Data